Acquisition / mergerNotableFiled on BSE ·

Entero Healthcare reports FY26 results, grants 7,300 ESOPs and acquires Vishal Surgicals

Entero Healthcare Solutions · Retailing

Arthneeti Research DeskPublished 1 min read
₹6,591 CrAcquisition / merger

Key highlights

  • Consolidated revenue from operations Rs. 65,912.12 million and profit for the year Rs. 1,458.40 million for the year ended March 31, 2026
  • Board granted 7,300 fresh employee stock options and approved allotment of 7,240 equity shares on exercise of options under the Entero Employee Stock Option Plan 2023
  • Acquisition of Vishal Surgicals and Vishal Surgicals & Medicals through subsidiary Sai Pharma Distributors Private Limited by slump sale; no value stated

Why it's rated notable: The filing names the acquisition and the Business Transfer Agreement but states no consideration or value, so the level stays at medium.

Figures checked against the filing by a second AI read, which corrected the first summary. About the business, not the share price.

Original filing

Announcement under Regulation 30 (LODR)-Acquisition

Read the filing on BSE (PDF) →

Companies guiding to strong growth

Ranked by management's own guidance on revenue and margins — not by us.

Rossell Techsys

Aerospace & Defense

Revenue growth 40%+Margin up 2%+

Sign up free to see all 6 →

See full rankings

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

More from Entero Healthcare Solutions

Other acquisition / merger filings this fortnight

All acquisition / merger filings →

Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.